NFATC4 Promotes Quiescence and Chemotherapy Resistance in Ovarian Cancer
A. J. Cole, M. Iyengar, P. OHayer, D. Chan, G. Greg Delgoffe, K. M. Aird, E. Yoon, S. Bai, R. J. Buckanovich
This study identifies NFATC4 as a regulator of quiescence and chemotherapy resistance in ovarian cancer, showing its role in promoting a non-proliferative state and poor prognosis.
bioRxiv · Jan 11, 2020Cancer Biology